GenomOncology

Over the past decade, the precision oncology industry has grown at an exponential rate, making it nearly impossible for clinicians to keep up with all available treatment options. As a result, clinicians often need data enablement and decision support tools to reduce the amount of time and research needed to identify relevant treatments for their patients. That’s where GenomOncology comes in. GenomOncology provides the healthcare community with data-driven insights to improve cancer care. Watch our latest video to learn more about precision oncology and how GenomOncology provides the solutions necessary to streamline and enhance precision oncology care. #precisiononcology #precisionmedicine #healthcare

GenomOncology’s Precision Oncology Platform (POP) is a clinical-omic data warehouse, storing all of the relevant clinical patient information from your EHR/LIS/LIMS and lab result information from your pathology lab, that powers its comprehensive set of end-to-end software solutions that streamline decision support and analytics. Additionally, POP combines both proprietary content and public and licensed data sets with your internal patient data to provide you the information necessary to advance patient treatment opportunities. Learn more here: https://lnkd.in/edBR8KMS #PrecisionMedicine #DecisionSupport #Analytics #PatientCare #Genomics

Watch our latest on-demand webinar with City of Hope’s Senior Vice President of Informatics, Samir Courdy, and GenomOncology's Vice President of Product Innovation, James Cole, PhD, as they break down how City of Hope leverages GenomOncology’s igniteIQ to streamline data enablement within their POSEIDON platform. During the webinar, learn more about: 👉City of Hope’s award-winning POSEIDON platform, and how it delivers patient-specific recommendations from real-world data 👉 The seamless integration of structured and unstructured patient and clinical data through HopeIQ, powered by GenomOncology’s igniteIQ 👉 How igniteIQ’s expert-in-loop model, biomarker normalization, and structure detection are revolutionizing NLP efficiency and accuracy Watch here: https://ow.ly/VOB350SQcn7 #DataEnablement #NLP #DataDrivenMedicine #igniteIQ #PatientCare

Watch our on-demand demo and explore the intricacies of the GO Pathology Workbench, presented by Ariel Schwartz, Senior Application Engineer, at GenomOncology. During the demo, learn how the GO Pathology Workbench: 👉 Streamlines somatic and germline variant analysis. 👉 Supports any instrument/assay/VCF or other file format, handling both NGS and non-NGS results. 👉 Annotates variants using a comprehensive database with 15+ sources, including ClinVar, ClinGen, and prediction algorithms. 👉 Seamlessly integrates into laboratory workflows (EHR/LIS/LIMS, Etc.). 👉 Centralizes workflows for all assays and tests through one installation, enabling molecular labs to analyze and report NGS tests in a unified workflow. 👉 Creates a comprehensive draft clinical genomic report. Learn more here: https://lnkd.in/eceJkT_i #Pathology #TertiaryAnalysis #Germline #Somatic #NGS

Watch our latest on-demand webinar where Samir Courdy, Senior Vice President of Informatics at City of Hope, and James Cole, PhD, Vice President of Product Innovation at GenomOncology, break down how City of Hope leverages GenomOncology’s igniteIQ to streamline data enablement within their POSEIDON platform. In this webinar, learn more about: 👉City of Hope’s POSEIDON platform, and how it delivers patient-specific recommendations from real-world data 👉 The seamless integration of structured and unstructured patient and clinical data through HopeIQ, an advanced Natural Language Processing (NLP) data curation solution powered by GenomOncology’s igniteIQ 👉 The remarkable impact of this data enablement strategy, and how it unlocks the true value of healthcare data Watch on-demand today: https://ow.ly/qOQb50SQ7kp #igniteIQ #NLP #DataEnablement #HopeIQ #HealthcareData

Check out our on-demand webinar with Dr. Andy Nelson, MD, PhD, Associate Professor in the Department of Laboratory Medicine and Pathology at University of Minnesota, and Matt Stachowiak, PhD, Vice President of Product Innovation at GenomOncology to learn more about: 👉UMN's Use of GO Pathology Workbench 👉UMN's Experience Launching Two GOAL-Based Assays 👉Demo of GO Pathology Workbench Watch here: https://lnkd.in/e36iGgbZ #Pathology #NGS #TertiaryAnalysis #Genomics #PatientCare

The world of precision medicine continues to evolve, making it increasingly difficult to stay on top of the latest developments, treatment, and clinical trials available for your patients. GenomOncology’s Precision Decision solution reduces this effort associated with identifying and analyzing relevant, up-to-date clinical trials and therapy options for patient treatment. The combination of automation and high-quality curated information results in an aggregation of available variant, disease, and patient data that empowers the accurate matching of patients to clinical trials and therapies, either in-house or globally. Learn more: https://lnkd.in/d_msk6pP #PrecisionDecision #ClinicalTrialMatching #DecisionSupport #GenomOncology

Watch our latest on-demand webinar where Samir Courdy, Senior Vice President of Informatics at City of Hope, and James Cole, PhD, Vice President of Product Innovation at GenomOncology, break down how City of Hope leverages GenomOncology’s igniteIQ to streamline data enablement within their POSEIDON platform. In this webinar, learn more about: 👉City of Hope’s POSEIDON platform, and how it delivers patient-specific recommendations from real-world data 👉 The seamless integration of structured and unstructured patient and clinical data through HopeIQ, an advanced Natural Language Processing (NLP) data curation solution powered by GenomOncology’s igniteIQ 👉 The remarkable impact of this data enablement strategy, and how it unlocks the true value of healthcare data Watch on-demand today: https://ow.ly/qOQb50SQ7kp #igniteIQ #NLP #DataEnablement #HopeIQ #HealthcareData

Are you interested in discovering how GenomOncology can enhance your lab's ability to process, validate, and report genetic testing results into actionable insights for clinicians? Watch our latest on-demand webinar featuring Dr. Andy Nelson, MD, PhD, Associate Professor in the Department of Laboratory Medicine and Pathology at the University of Minnesota (UMN), and Matt Stachowiak, PhD, Vice President of Product Innovation at GenomOncology. During the webinar, learn more:  👉 UMN's use of GO Pathology Workbench 👉 UMN's Experience Launching Two GOAL-Based Assays 👉 Demo of GO Pathology Workbench Watch now: https://lnkd.in/e36iGgbZ #tertiaryanalysis #pathology

Enhance clinical decision-making and streamline workflows with GenomOncology’s Pathology Workbench (GO PWB).   Our end-to-end tertiary analysis solution integrates directly with any lab system, automates variant interpretation, matches patients to the most up-to-date personalized therapies and clinical trials, and produces a fully customizable report. Learn more about how GO PWB can transform your data here: https://lnkd.in/eXiwqC32 #Pathology #PrecisionMedicine #TertiaryAnalysis